Control-IQ the first AID system with automatic correction boluses and no fingersticks CGM (Dexcom G6); cleared for those ages 14 and older; launch in January 2020
Research
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
28 readers recommended
Farxiga’s heart health benefits were the same in people with and without diabetes, as well as across a spectrum of baseline A1C levels
98 readers recommended
Ozempic, a once weekly injectable GLP-1 agonist drug, is now approved to reduce the risk of heart attack and stroke. Rybelsus (a pill version of Ozempic) is confirmed to...
30 readers recommended
A new study shows that physical activity can add years to your life. Is this enough to motivate behavior change?
40 readers recommended
The first study of people with diabetes and COVID-19 reveals troubling statistics and risk factors
54 readers recommended
Results from the VERTIS-CV trial show that SGLT-2 inhibitor Steglatro benefits heart and kidney health; hear expert opinions on SGLT-2 and GLP-1 medications
32 readers recommended
dQ&A surveyed 2,540 CGM users with type 1 or type 2 diabetes to find out how aware they are of their own time in range: 87% of respondents knew how much time they...
36 readers recommended
What is the link between vision loss and mental health outcomes, and how can eye exams tell us what is going on in the brain and the body?
43 readers recommended
Trulicity can now be prescribed to reduce the risk of stroke and heart attack in adults with type 2 diabetes and with heart disease or those who at risk for heart disease
32 readers recommended
JDRF's Mission Summit in La Jolla, California highlighted JDRF's efforts into multiple cures, plus more on complications
39 readers recommended
In exciting news for digital diabetes prevention programs, a new study showed that highly engaged participants – those who more frequently engaged in food logging,...
38 readers recommended
We bring you the most exciting news from day one, including updates on automated insulin delivery, ways that technology can reduce hypoglycemia, and new physical...
34 readers recommended
Check out the third day highlights from ADA’s virtual 80th Scientific Sessions – including new insights on off label use in type 1 diabetes, type 2 diabetes remission,...
39 readers recommended
In exciting news, Tandem announced expanded clearance for the hybrid closed loop Control-IQ. The system is now available for children ages 6-13
33 readers recommended
Recent results from Omada Health’s Digital Diabetes Prevention Program show reductions in A1C and body weight over a 12-month period. This digital tool may be especially...
37 readers recommended
The RADIANT study aims to define unusual forms of diabetes, to help diagnose and treat these conditions. RADIANT is recruiting people who have been diagnosed with...
41 readers recommended
At the ADA Postgraduate 2021 virtual conference, Dr. Samuel Dagogo-Jack discussed how intensive lifestyle changes can lead to prediabetes remission and prevent...
42 readers recommended
Latest results presented at the European Society of Cardiology conference show that SGLT-2 inhibitor therapies Jardiance and Farxiga clearly lead to heart and kidney...
39 readers recommended
Experts discussed the greatest challenges in diabetes in 2020, including the COVID-19 pandemic, and the most critical changes we need to make to address them during...
43 readers recommended
Highlights from last week’s European Association for the Study of Diabetes’ (EASD) virtual 2020 conference included announcements on the Guardian Sensor 4 Continuous...